Skip to main content

Table 2 Demographic characteristics of participants

From: A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells

 

Group

Placebo

Auto-BM-MNC

Allo-WJ-MSCs

Sex

Male, n (%)

5 (50)

7 (100)

5 (71)

Female, n (%)

5 (50)

2 (29)

Age (years)

18–50 years, n (%)

51–85 years, n (%)

9 (100)

7 (100)

6 (100)

Mean ± SD

73.11 ± 10.56

72.43 ± 5.06

78.33 ± 5.85

Median

77

71

77.50

Min/max

58/84

67/80

70/85

  1. Auto-BM-MNC autologous bone marrow mononuclear cells, allo-WJ-MSCs allogenic Wharton jelly-derived mesenchymal stem cells and SD standard deviation